Risperidone in the treatment of schizophrenia

10.1001/archpsyc.1988.01800330013001

Seeman P, Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse I 987

10.1073/pnas.40.4.228

10.1002/ddr.430080124

Niemegeers CJ, 1990, Encephale, 16, 147

Bersani G, 1986, Curr Ther Res, 40, 492

Hildebrand J, 1987, Curr Ther Res, 41, 298

10.1097/00002826-199012000-00003

10.1093/schbul/14.2.297

Meltzer HY, 1989, J Pharmacol Exp Ther, 251, 238

Leysen JE, 1988, J Pharmacol Exp Ther, 247, 661

10.1007/BF00172961

Janssen PAJ, 1988, J Pharmacol Exp Ther, 244, 685

Roose K, 1988, Acta Psychiatr Beig, 88, 233

10.1016/0920-9964(89)90034-0

10.1007/BF00589890

Borison RL, 1992, Psychopharmacol Bull, 28, 213

10.1097/00004714-199302000-00004

Kay SR, 1987, Psychiatr Dcv, 2, 79

10.1093/schbul/13.2.261

10.1016/0165-1781(88)90038-8

Guy, 1976, ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338

Chouinard G, 1980, Jones BD: Extrapyramidal Symptom Rating Scale. Can J Neurol Sci, 7, 233

Scandinavian Society of Psychopharmacology Committee of Clinical Investigations (UKU), 1987, Acta Psychiatr Scand Suppl, 334, 81

Overall JE, 1962, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep, 10, 799

User's Guide, 1990, Version 6, 4

10.1111/j.1600-0447.1992.tb01473.x

Muller-Spahn F and the International Risperidone Research Group, 1992, Clin Neuropharmacol, 91A

10.1001/archpsyc.1990.01810200062009